TY  - GEN
AU  - O'Day,Steven J
AU  - Eggermont,Alexander M M
AU  - Chiarion-Sileni,Vanna
AU  - Kefford,Richard
AU  - Grob,Jean Jacques
AU  - Mortier,Laurent
AU  - Robert,Caroline
AU  - Schachter,Jacob
AU  - Testori,Alessandro
AU  - Mackiewicz,Jacek
AU  - Friedlander,Philip
AU  - Garbe,Claus
AU  - Ugurel,Selma
AU  - Collichio,Frances
AU  - Guo,Wei
AU  - Lufkin,Joelle
AU  - Bahcall,Safi
AU  - Vukovic,Vojo
AU  - Hauschild,Axel
TI  - Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma
SN  - 1527-7755
PY  - 2013///0506
KW  - Antineoplastic Agents, Phytogenic
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Double-Blind Method
KW  - Humans
KW  - Hydrazines
KW  - L-Lactate Dehydrogenase
KW  - blood
KW  - Melanoma
KW  - drug therapy
KW  - Paclitaxel
KW  - Skin Neoplasms
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2012.44.5585
ER  -